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The effect of the treatment of HeLa ¢¢11s with a tum0r-promoting phorbol ester. 12-o-tetradecanoyl-phorbol-13-aectate (TPA) on the expression 
of the genes for the calpain family has b~n examined. Among the mRNAs for the calpain family, onl~¢ the mRNA for the large subanit of human 
m-calpain (calpain mL) was specifically induced by treatment of cells with TPA, suggesting its specific function in response to cellular stimuli. The 
effect of TPA on the expression of the calpain mL gene was further examined using fusion genes containing the promoter/enhancer region of the 
calpain mL 8ene fused upstream of the bacterial chloramphenieol aeetyitransferase (CAT) geneo showing that the promoter/enhancer sgqucn~ 
of the calpain mL gene contains a c/s-acting clement which responds to TPA and activates transcription of the downstream s~ueng¢. 
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1. INTRODUCTION 
Three types of calpain (calcium-dependem protease, 
calcium-activated neutral pretense, CANP) isozymes, 
m-, g-, and n-calpain, have been found. Although n- 
calpain is expressed only in muscle, other two types of 
calpain, m- and/.t-, locate in various animal tissues and 
cells [1,2]. Ubiquitous distribution of m- and/z-calpains 
suggests their physiological importance especially in the 
cellular functions regulated by Ca -'+ [1,2]. Although 
there is a clear difference between the two calpain 
isozymes, m- and/z-, in the Ca '~ concentrations re- 
quired for activation, no clear differences are found in 
other biochemical properties such as substrate specific- 
ity [i,2]. This suggests that these two isozymes act in 
distinct physiological situations. 
Previous experiments have established that both m- 
and/.t-calpains are composed of heterogeneous sub- 
units, large (L) and small ($), where the small subunit 
is common to both isozymes [3]. Thus the difference in 
the Ca-~+-requirements resides in the large subunits, mL 
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and eL. The structural similarity of these ealpain pro- 
teins, mL,/zL, S and the third large subunit, nL, sug- 
gests their evolutionary relationship, whereas their 
genes locate on four distinct human chromosomes, re- 
spectively [4]. 
Isolation and characterization f the promoter/en- 
hancer egion of the human calpain mL gene revealed 
the presence of tandemly repeated negative nhancer- 
like cis.acting elements which negatively regulate the 
transcription of the calpain mL gene as well as a pro- 
moter sequence [5]. The promoter/enhancer sequence of 
the calpain mL gene contains a sequence motif called 
TRE (TPA-response lement) shown to be involved in 
transcriptional activation mediated by protein kinase C, 
a major target of TPA [6-8]. 
In the present study, we examined the expression of 
the genes for the calpain family as well as that for the 
specific proteinous inhibitor, calpastatin, and found 
that TPA specifically induces the expression of the cal- 
pain mL mRNA and the induction is very likely regu- 
lated at the level of transcription through the promoter/ 
enhancer region of the calpain mL gene. 
2. EXPERIMENTAL 
2. I. Northern blot analysis 
HeLa cells were cultured in Ea~e's miminum essential medium 
(E-MEM) supplemented with 5% fetal calf serum. After incubation 
with TPA (100 ng/ml) for the indicated time, total RNA was prepared 
as described [5] and subjected to Northern hybridization following a 
standard procedure [9]. DNA probes used for hybridization were 
eDNA inserts of plasmids p21 (haman calpain mL} [10], p31 (human 
calpain,uL) [I i]. p276 (human calpain S) [12], and pCl2! 3 (.,"at calpas- 
tatin) [13]. A human fl.actin g, gnomic DNA segment was purchased 
from Wake (Osaka. Japan). 
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2,2. DNA tmnsfection a d CA T assay 
A rat flbroblast 3Yl cell stable transf¢ctants, W3, was cultured as 
described [14] and used in the transient expression experiments, The 
constructs of the CAT.calpain mL fusion genes, p-460/-20CAT, 
p-20~-80TKCAT, and pTKCAT was described previously [5l, Cell 
,'.xtracts equivalent to 15 mg of protein were used for the CAT assay. 
The CAT activity of each construct was determined byat least wo 
independent transfection experiments and the average value is shown. 
3. RESULTS AND DISCUSSION 
3.1. Specific induction of the mRNA for the large subunit 
of  human m.calpain in HeLa cells treated with a 
tumor-promoting pho~'bol esteL TPA 
In order to further obtain an evidence supporting the 
difference of  these two ealpain isozymes in various 
physiological situations, we examined the expression of 
their genes in HeLa cells. We have previously isolated 
eDNA clones encoding mL, ,uL, S, and calpastatin. 
These mRNA species were shown to be expressed ubiq- 
uitously in a variety of tissues and cells [1]. In order to 
examine whether the amount of  these calpain proteins 
change in response to a certain extracellular stimuli, we 
examined their mRNA ,,'xpression by Northern blotting 
using corresponding eDNA as hybridization probes 
after treatment of HeLa cells with TPA which is shown 
to activate protein kinase C (PKC) in cells and activates 
PKC-mediated signaling pathway [6--8]. 
Exponentially growing HeLa cells were treated with 
TPA, total RNA was extracted, and were analyzed in 
terms of Northern blot analysis. As shown in Fig. 1, all 
the calpain mRNAs (mL,/.tL, and S) and calpastatin 
mRNA were expressed in HeLa cells and the amount 
o fmRNA for/zL did not change. However, mL mRNA 
greatly increased upon treatment of  ceils with TPA for 
several hours. The mRNAs for S and calpastatin seem 
to increase to some extent. This is the first demonstra- 
tion that the amount of calpain mRNA change in re- 
sponse to an extracellular stimuli, Moreover, it is quite 
interesting that only mL mRNA was induced and the 
other mRNAs did not change upon TPA treatment, 
suggesting that the amount of mL and thus that of 
m-calpain is regulated under intra-cellular signaling sys- 
tem involving PKC. 
3.2. The induction of calpain mL mRNA is regulated 
through a cis-acting transcriptional elements 
In order to ascertain whether the induction ofcalpain 
mL mRNA is regulated at the transcriptional level, we 
next examined the transcriptional ctivity of the cloned 
promoter/enhancer region of the human calpain mL 
gone. A set of  DNA construct which contains the pro- 
moter/enhancer region of the calpain mL gone fused 
upstream of the bacterial CAT structural sequence was 
transfected to a rat fibrohlast cell clone W3, which is a 
stable transformant of 3YI cell, W3 contains an ex- 
ogenous sequence encoding a rabbit PKC= eDNA 
under the control of mouse mammary tumor virus 
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Fig. 1. Expression of calpain and calpastatin mRNAs in HeLa cells 
treated with TPA. Total cellular RNA (2gg/lane) isolated from HeLa 
cells cultured in the presence ofTPA (1130 ng/ml) for various lengths 
was analyzed by Northern blot analysis. Length of TPA treatment is 
shown as follows: (lane 1) 0 h; (lane 2) 0,5 h; (lane 3) I h; (lane 4) 2 
h; (lane 5) 4 h; (lane 6) S h, Probes used were calpain mL (mL), ealpain 
/aL (/zL), calpain S (S), calpastatin (CS), and fl-actin, Arrow-heads 
indicate 28S and 18S ribosomal RNAs, Arrows indicate correspond. 
ing mRNA species. Small arrow in S indicates the cross-hybridization 
with rRNA. 
(MMTV) long terminal repeat (LTR) promoter ~vhich 
responds to dexamethasone (Dex) and results in the 
increase of  the transcgption of the downstream se- 
quence [14]. W3 cells treated with Dex express an ap- 
proximately 20-fold amount of PKCg compared with 
the endogenous protein and is highly responsive to TPA 
when examined in terms of transcriptional ctivation of 
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Fig. 2. "l'PA-respov.sive expression of the CAT.ealpain mL fusion 
genes. The fragments ofcalpain mL gene upstream sequences inserted 
into the CAT ¢~pression plasmid pKSCAT or pTKCAT [5] are shown 
as arrows. The CAT activity of each construct was determined and 
indicated as percent acctylation as described in section 2, Open box 
shows the promoter of HSV TK gone which includes both CAAT box 
(*) and TATA box (o), Closed box shows bacterial CAT gone. 
the reporter CAT fusion gone containing TPA-response 
elements uch as TRE and serum-response element 
(SRE) (data not  shown). 
pTKCAT contains the promoter sequence of the her- 
pes simplex virus (HSV) thymidine kinase (TIC) gene 
and is constitutively active with or without TPA (Fig. 
2). Addition of the promoter sequence (P region) of the 
calpain mL gene upstream of the TK gene promoter 
(p-202/-80TKCAT) does not alter the CAT activity 
without TPA. However, the CAT activity of p-202/ 
-80TKCAT is enhanced 4-fold by treatment with TPA. 
This indicates that *.he -202/-80 (P) region contains 
cis-acting element(s) which responds to TPA and en- 
hances the transcription. As previously reported, this 
region of the calpain mL gone promoter contains a 
sequence motif TGAATCA at -132 closely related to 
the collagenase TPA-response lement (TRE) which 
binds AP-1 [5,15]. Thus, it is quite likely that this se- 
quence is involved in the transcriptional ctivation me- 
diated by the calpain mL promoter sequence. 
As described in the previous report, the upstream 
sequence of the calpain mL promoter is proceeded by 
tandemly reiterated negative enhancer-like lements 
(NI to N4), which independently repress promoter ac- 
tivities independent of their orientation [5]. Then the 
effect of these negative lements on the transcriptional 
activation mediated by the promoter sequence in re- 
sponse to TPA was examined. As shown in Fig. 2, addi- 
tion of N 1 (-260/-202) and N2 (-460/-260) regions to 
the promoter sequence of the calpain mL gone (p-460/ 
-20CAT) negatively regulates the transcription of the 
cognate gene with or without TPA. Although the CAT 
activity of p-460/-20CAT is a few-fold lower than that 
of p-202/-80TKCAT, the TPA responsiveness of 
p-460/-20CAT was almost the same level as that of 
p-202/-80TKCAT. This means that the negative re. 
glen of calpain mL gene (N1 and N2) can negatively 
regulates the transcriptional ctivity of its own pro- 
moter but it cannot inhibit the induction ofcalpain mL 
gone by TPA. These results indicate that the cloned 
promoter/enhancer s quence of the calpain mL gone 
contains a TPA-response lement most likely TRE at 
position -132. It is also quite likely that the induction 
of calpain mL mRNA is regulated at the level of tran- 
scription through this TPA-response lement. 
The fact that calpain mL mRNA is induced by TPA, 
whereas/.tL mRNA is not, suggests the specific induc- 
tion of m-calpain upon TPA treatment of cells. This 
implies that m- and/z-calpains are involved in distinct 
cellular functions; m-calpain functions in inducible cel- 
lular events in response to various stimuli, whereas ,tt- 
calpain plays constitutive function. Although it is not 
clear in this study whether the human calpain gone for 
the small subunit (calpain S) mRNA is induced by TPA 
or not, it is possible that the expression of both large 
and small subunits of human calpain mL genes is co- 
regulated at the transcription level, because the human 
calpain Sgene shares high sequence homology with the 
human mL gone in the corresponding 5' upstream re- 
gion (-360 to -60: 50% homology) [5]. 
In vitro experiments using purified caipain has re- 
vealed that it causes limited digestion of a set of proteins 
which leads to irreversible molecular transformation f
these substrate proteins [1]. The cellular proteins which 
are digested by calpain involves receptors for insulin 
and epidermal growth factors, protein kinases uch as 
PKC, and cytoskeletal proteins. It is also reported that 
activation of calpain involves irreversible transforma- 
tion of itself; auto-digestion [2]and the activated calpain 
species is very unstable [16]. This implies that calpains 
are used only once in cells, and that activation of eel- 
pain requires a mechanism which compensates the used- 
up molecules and prepare for the next signal. The induc- 
tion of calpain mL gone by TPA suggests that various 
physiological stimuli may induce the synthesis of m- 
calpain to maintain the level of this protein. 
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